Central Laboratory, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, 523059, China.
Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, Guangdong Medical University, Dongguan, 523808, China.
Curr Stem Cell Res Ther. 2024;19(6):785-797. doi: 10.2174/1574888X18666230427112930.
Chronic liver disease is a known risk factor for the development of liver cancer, and the development of microRNA (miRNA) liver therapies has been hampered by the difficulty of delivering miRNA to damaged tissues. In recent years, numerous studies have shown that hepatic stellate cell (HSC) autophagy and exosomes play an important role in maintaining liver homeostasis and ameliorating liver fibrosis. In addition, the interaction between HSC autophagy and exosomes also affects the progression of liver fibrosis. In this paper, we review the research progress of mesenchymal stem cell-derived exosomes (MSC-EVs) loaded with specific miRNA and autophagy, and their related signaling pathways in liver fibrosis, which will provide a more reliable basis for the use of MSC-EVs for therapeutic delivery of miRNAs targeting the chronic liver disease.
慢性肝脏疾病是肝癌发展的已知风险因素,而 miRNA(微小 RNA)肝脏治疗的发展受到将 miRNA 递送至受损组织的困难的阻碍。近年来,许多研究表明,肝星状细胞(HSC)自噬和外泌体在维持肝脏内稳态和改善肝纤维化方面发挥着重要作用。此外,HSC 自噬和外泌体之间的相互作用也影响肝纤维化的进展。本文综述了负载特定 miRNA 和自噬的间充质干细胞衍生的外泌体(MSC-EVs)及其在肝纤维化中的相关信号通路的研究进展,为利用 MSC-EVs 递送来靶向慢性肝脏疾病的 miRNA 提供更可靠的依据。